A new serological study conducted at Sheba Medical Center in Ramat Gan has shown 98% of hospital workers who received the second dose of the coronavirus vaccine have developed a high level of antibodies to fight off the virus.

The study of 102 samples, taken a week after Israel began administering the second dose — when the vaccine is expected to reach peak effectiveness — showed most vaccinees had higher antibody counts than among those who have recovered from COVID-19.

Bill Oxford/iStock

Read more…